Qisda forecast a modest recovery in the second half of 2025 but warned profits remain uncertain amid tariff and currency headwinds. The Taiwanese electronics and medical solutions company reported stronger second-quarter results across all business lines, with healthcare and intelligent solutions setting records. Healthcare revenue topped NT$7 billion (US$234 million) for a third consecutive quarter, while intelligent solutions reached NT$9.5 billion for the first time. Both segments are projected to sustain growth in the third quarter.